Effectiveness and Cost of a Quantitative and Qualitative Nutritional Supplementation in Elderly Patients

Status

Terminated

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00560729

Enrollment

Registered

2007-11-20

Start date

2003-10-31

Completion date

2007-07-31

Last updated

2013-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Denutrition

Keywords

elderly people

Brief summary

Evaluation of the effectiveness and the costs of a quantitative and qualitative nutritional supplementation in elderly patients

Interventions

DIETARY_SUPPLEMENTRenutryl 500

DIETARY_SUPPLEMENTGenerique

DIETARY_SUPPLEMENTGenerique + Renutryl 500

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

70 Years to No maximum

Healthy volunteers

Inclusion criteria

* Hospitalization into a geriatric care unit * age \> 70 years * C reactive protein \> 30 mg/l * 25 \< albumin \< 35 g/l * 130 \< Na \< 145 mmol/l * BMI \< 22 * weight loss \> 10 % within the last 6 months * MNA \< 23.5

Exclusion criteria

* diabetes mellitus * severe digestive failure * enteral or parenteral nutrition * renal,cardiac or digestive failure * lactose intolerance * terminal phase severe pathology * MMS \< 15

Design outcomes

Primary

Measure	Time frame
Nutritional Risk Index	At J0, J21, J42

Secondary

Measure	Time frame
Measure of body mass index (BMI), Mini Nutritional Assessment, Fat mass,lean mass, serum albumin and transthyretin,Activities of Daily Living (ADL), ingesta and morbidity.	—
Tolerance	Daily

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026